-
1 Comment
Sinocare Inc is currently in a long term downtrend where the price is trading 11.1% below its 200 day moving average.
From a valuation standpoint, the stock is 12.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Sinocare Inc's total revenue rose by 25.5% to $557M since the same quarter in the previous year.
Its net income has increased by 8.8% to $91M since the same quarter in the previous year.
Finally, its free cash flow grew by 1240.3% to $73M since the same quarter in the previous year.
Based on the above factors, Sinocare Inc gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001CJ0 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 9B |
|---|---|
| PE Ratio | 66.08 |
| Target Price | 22.88 |
| Beta | -0.12 |
| Dividend Yield | None |
Sinocare Inc. provides digital diabetes management products in the People's Republic of China. It offers blood and pressure products, multiparameter testing, and hospital and primary healthcare products; H102 Air, a hemoglobin monitoring system; and Safe AQ UA II, a uric acid monitoring system. The company also exports its products. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300298.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026